Catalyst Wire Dossier Catalyst Wire Dossier

ARD-885

· Artivila (Shenzhen) Innovation Center, Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARD-885, covering 2025-12-05 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetic, and Food Effects of ARD-885 Film-coated Tablets in Healthy Chinese Subjects and Patients With Rheumatoid Arthritis [Phase 1]

See pricing